Differential expression of VIP/PACAP receptor genes in breast, intestinal, and pancreatic cell lines.
Differential expression of VIP/PACAP receptor genes in breast, intestinal, and pancreatic cell lines.
复制标题
VIP/PACAP 受体基因在乳腺、肠和胰腺细胞系中的差异表达。
DOI:
10.1016/0304-3835(95)03768-r
复制
发表时间:
1995
期刊:
影响因子:
9.7
通讯作者:
Bravo,DT
中科院分区:
文献类型:
--
作者:
Waschek,JA;Richards,ML;Bravo,DT
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP) are structurally-related neuropeptides that function as trophic factors in addition to their more classical roles as neurotransmitters. Binding and molecular cloning studies have shown that their actions are mediated by receptors encoded by at least three different genes. VIP binding has been demonstrated on many tumor types, and radiolabeled VIP has recently been used as a novel method to localize intestinal tumors in humans and their sites of metastasis. To determine the receptor subtype and level of gene expression, we screened breast, intestinal, and pancreatic, cell lines by Northern blot analysis. Breast lines expressed VIP/PACAP1receptor mRNA levels comparable to intestinal lines, in agreement with the studies showing particularly high VIP binding in these tumors and their derived cell lines. Pancreatic cell lines expressed mRNA for several receptor types. This extends the potential utility of VIP and PACAP in the localization of tumors, and because VIP and PACAP may regulate the growth rate of some tumors by autocrine or other mechanisms, the identification of receptor subtypes on these lines sets the stage for studies in which the activity of these individual receptors in growth and other processes can be investigated.